PTSD
608
106
126
325
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
121 trials with published results (20%)
Research Maturity
325 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.6%
28 terminated out of 608 trials
92.1%
+5.5% vs benchmark
7%
43 trials in Phase 3/4
37%
121 of 325 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 325 completed trials
Clinical Trials (608)
COPEWeb Training for Providers
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days
The Effectiveness of Group-Delivered Guided Written Exposure Therapy for PTSD and CPTSD Among Adolescents : A Pilot Study
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
Treatments for Insomnia in Veterans With PTSD
Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)
Key Dimensions of PTSD and ED
Neuroendocrine Risk for PTSD in Women
Peer-led Trauma Therapy for Re-entry
Vagal Nerve Stimulation in mTBI
Empowerment Self Defense Program for Adult Native Women Survivors of Sexual Violence
FLOAT for Healthcare PTSS
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Ketamine-enhanced Prolonged Exposure Therapy in PTSD
Temporal Interference in Psychiatry (TIP): Neuromodulation Using Temporal Interference
Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder
Patient Engagement in PTSD Treatment (PEP)
Cervical Plexus Hydrodissection With D5W for PTSD
Intranasal Insulin for Posttraumatic Stress Disorder